Atacicept Recruiting Phase 2 Trials for Berger Disease / IgA Nephropathy (IgAN) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04716231Atacicept in Subjects With IgA Nephropathy